Patents by Inventor Robert J. Nordstrom

Robert J. Nordstrom has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 6839661
    Abstract: A method and system for normalizing optical spectra using a non-uniform segment normalization. A spectrum is obtained and is represented as a function of wavelength as an amplitude at each of a plurality of wavelengths. At least one segment of the spectrum is selected, each selected segment being bounded by an upper wavelength and a lower wavelength. A normalization factor is computed as the sum of the areas for each of the selected segments. The spectrum is normalized by dividing at least one amplitude of the spectrum by the normalization factor. Segments can be selected with different wavelength ranges, that is, segments can be non-uniform. Test specimens can be categorized based on an analysis of normalized spectra. In particular, the specimen to be tested can be human cervical tissue, and the state of health of the tissue can be determined.
    Type: Grant
    Filed: December 15, 2000
    Date of Patent: January 4, 2005
    Assignee: MediSpectra, Inc.
    Inventors: Peter J. Costa, Kwong Hui, Robert J. Nordstrom
  • Publication number: 20020133073
    Abstract: A system and method for classifying specimens using a plurality of spectral data types. Spectra are recorded as amplitudes at a series of discrete wavelengths. Pluralities of reference spectra are recorded for specimens having known conditions. A spectrum of a first type is observed for a test specimen. The specimen is characterized as to a first known condition. In the event that the specimen does not exhibit the first known condition, a spectrum of a second type is observed and analyzed to determine which of a plurality of conditions is to be ascribed to the test specimen. In some embodiments, the test specimen can comprise human cervical tissue, and the known conditions can include normal health, metaplasia, CIN I and CIN II/III.
    Type: Application
    Filed: February 8, 2002
    Publication date: September 19, 2002
    Inventors: Robert J. Nordstrom, Peter J. Costa, Kwong Hui, Ross Flewelling, Howard Kaufman
  • Publication number: 20020107668
    Abstract: A method and system for normalizing optical spectra using a non-uniform segment normalization. A spectrum is obtained and is represented as a function of wavelength as an amplitude at each of a plurality of wavelengths. At least one segment of the spectrum is selected, each selected segment being bounded by an upper wavelength and a lower wavelength. A normalization factor is computed as the sum of the areas for each of the selected segments. The spectrum is normalized by dividing at least one amplitude of the spectrum by the normalization factor. Segments can be selected with different wavelength ranges, that is, segments can be non-uniform. Test specimens can be categorized based on an analysis of normalized spectra. In particular, the specimen to be tested can be human cervical tissue, and the state of health of the tissue can be determined.
    Type: Application
    Filed: December 15, 2000
    Publication date: August 8, 2002
    Inventors: Peter J. Costa, Kwong Hui, Robert J. Nordstrom
  • Patent number: 6421553
    Abstract: A system and method for classifying tissue by application of discriminant analysis to spectral data. Spectra are recorded as amplitudes at a series of discrete wavelengths. Pluralities of reference spectra are recorded for specimens having known conditions. The reference spectra are subjected to discriminant analysis to determine wavelength regions of interest for the analysis. A plurality of amplitudes are selected for the analysis, and are plotted in an N-dimensional space. For each plurality of reference spectra corresponding to a specific known condition, a characteristic point is determined and plotted, the characteristic point representative of the known condition. A test spectrum is recorded from a test specimen, and the plurality of amplitudes corresponding in wavelength to the wavelength regions of interest are selected. A characteristic point in N-dimensional space is determined for the test spectrum.
    Type: Grant
    Filed: December 15, 2000
    Date of Patent: July 16, 2002
    Assignee: MediaSpectra, Inc.
    Inventors: Peter J. Costa, Kwong Hui, Robert J. Nordstrom
  • Patent number: 6385484
    Abstract: A system and method for classifying specimens using a plurality of spectral data types. Spectra are recorded as amplitudes at a series of discrete wavelengths. Pluralities of reference spectra are recorded for specimens having known conditions. A spectrum of a first type is observed for a test specimen. The specimen is characterized as to a first known condition. In the event that the specimen does not exhibit the first known condition, a spectrum of a second type is observed and analyzed to determine which of a plurality of conditions is to be ascribed to the test specimen. In some embodiments, the test specimen can comprise human cervical tissue, and the known conditions can include normal health, metaplasia, CIN I and CIN II/II.
    Type: Grant
    Filed: December 15, 2000
    Date of Patent: May 7, 2002
    Assignee: MediSpectra, Inc.
    Inventors: Robert J. Nordstrom, Peter J. Costa, Kwong Hui, Ross Flewelling, Howard Kaufman
  • Publication number: 20010020132
    Abstract: A system and method for classifying specimens using a plurality of spectral data types. Spectra are recorded as amplitudes at a series of discrete wavelengths. Pluralities of reference spectra are recorded for specimens having known conditions. A spectrum of a first type is observed for a test specimen. The specimen is characterized as to a first known condition. In the event that the specimen does not exhibit the first known condition, a spectrum of a second type is observed and analyzed to determine which of a plurality of conditions is to be ascribed to the test specimen. In some embodiments, the test specimen can comprise human cervical tissue, and the known conditions can include normal health, metaplasia, CIN I and CIN II/II.
    Type: Application
    Filed: December 15, 2000
    Publication date: September 6, 2001
    Inventors: Robert J. Nordstrom, Peter J. Costa, Kwong Hui, Ross Flewelling, Howard Kaufman